Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added above the 403 error page, and the footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:57:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T01:04:51.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The study record page now renders a 403 Forbidden error, replacing the expected study details with an access-restricted page. This indicates a permissions issue rather than a change to the study data.
    Difference
    17%
    Check dated 2026-09-23T01:09:05.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.6 to v3.7.0, indicating a newer version of the page. This appears to reflect a software/content revision rather than a substantive update to study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-09-16T00:16:21.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    New revision tag added: 'Revision: v3.6.6' replacing the previous 'Revision: v3.6.5'. This appears to be a routine platform update and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:06.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small site update. It does not modify the displayed study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-11T21:46:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.